Risedronate and Parathyroid Hormone to Reverse Osteoporosis Caused by Chronic Steroid Use

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

March 31, 2009

Study Completion Date

May 31, 2009

Conditions
Osteoporosis
Interventions
DRUG

Risedronate

One 35mg tab of risedronate/placebo taken once a week for one year.

DRUG

Parathyroid Hormone

This medication comes in a pre packaged 28 day supply pen. Medication is administered once a day by a subcutaneous injection (under the skin) into the thigh or abdomen. For this study, this medication will be taken for one year.

Trial Locations (1)

95817

UC Davis General Medicine Research Clinic, Sacramento

All Listed Sponsors
collaborator

University of California, San Francisco

OTHER

lead

University of California, Davis

OTHER

NCT00221299 - Risedronate and Parathyroid Hormone to Reverse Osteoporosis Caused by Chronic Steroid Use | Biotech Hunter | Biotech Hunter